HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
RPS13
ribosomal protein S13
Chromosome 11 · 11p15.1
NCBI Gene: 6207Ensembl: ENSG00000110700.8HGNC: HGNC:10386UniProt: P62277
285PubMed Papers
20Diseases
6Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedHub Gene
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
mRNA 5'-UTR bindingmembraneextracellular exosomecytosolic ribosomeinfluenzaDuchenne muscular dystrophycystic fibrosisCOVID-19
✦AI Summary

RPS13 (ribosomal protein S13) is a structural component of the small ribosomal subunit essential for protein synthesis 1. As part of the small subunit processome, RPS13 participates in ribosome biogenesis within the nucleolus, contributing to pre-rRNA processing, folding, and modifications 1. Beyond its canonical ribosomal function, RPS13 demonstrates remarkable expression stability across diverse cell types and experimental conditions, making it an excellent reference gene for gene expression normalization studies 23. However, RPS13 also plays oncogenic roles in cancer progression. In gastric cancer, RPS13 is overexpressed and promotes tumor growth by accelerating G1 to S phase cell cycle transition through down-regulation of the tumor suppressor p27(Kip1) 4. Additionally, specific noncoding ultraconserved elements can act as silencers of RPS13, suggesting complex regulatory mechanisms in cancer 5. In Kaposi's sarcoma, RPS13 is downregulated and its reduced expression promotes cellular proliferation, migration, and angiogenesis 6. The protein also functions in stem cell niche homeostasis, regulating germline stem cell renewal and differentiation through Rho1-mediated signaling pathways 7. These findings reveal RPS13's dual nature as both a stable housekeeping gene and a context-dependent regulator of cellular proliferation and cancer progression.

⚠Limited data available — This gene has 0 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
influenzaOpen Targets
0.46Moderate
Duchenne muscular dystrophyOpen Targets
0.46Moderate
cystic fibrosisOpen Targets
0.39Weak
COVID-19Open Targets
0.37Weak
severe acute respiratory syndromeOpen Targets
0.37Weak
aniridiaOpen Targets
0.10Suggestive
Becker muscular dystrophyOpen Targets
0.10Suggestive
non-Hodgkins lymphomaOpen Targets
0.09Suggestive
genetic disorderOpen Targets
0.09Suggestive
hepatitis B virus infectionOpen Targets
0.08Suggestive
gastric cancerOpen Targets
0.08Suggestive
neurodegenerative diseaseOpen Targets
0.08Suggestive
Alport syndromeOpen Targets
0.07Suggestive
arthritisOpen Targets
0.07Suggestive
cystinosisOpen Targets
0.07Suggestive
diffuse large B-cell lymphomaOpen Targets
0.07Suggestive
Dravet syndromeOpen Targets
0.07Suggestive
epilepsyOpen Targets
0.07Suggestive
hemophilia AOpen Targets
0.07Suggestive
hemophilia BOpen Targets
0.07Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets6
ATALURENApproved
80S Ribosome modulator
Duchenne muscular dystrophy
CITATUZUMAB BOGATOXPhase I
Epithelial cell adhesion molecule binding agent
ELX-02Phase II
80S Ribosome modulator
cystic fibrosis
MT-3724Phase II
80S Ribosome inhibitor
diffuse large B-cell lymphoma
TELIMOMAB ARITOXPhase II
T-cell surface glycoprotein CD5 binding agent
hepatitis B virus infection
ZOLIMOMAB ARITOXPhase II
T-cell surface glycoprotein CD5 binding agent
arthritis
Related Genes
EEF1B2Protein interaction100%EEF1GProtein interaction100%EEF2Protein interaction100%EIF5AProtein interaction100%ETF1Protein interaction100%FANCEProtein interaction100%
Tissue Expression6 tissues
Ovary
100%
Bone Marrow
60%
Brain
53%
Lung
49%
Heart
41%
Liver
36%
Gene Interaction Network
Click a node to explore
RPS13EEF1B2EEF1GEEF2EIF5AETF1FANCE
PROTEIN STRUCTURE
Preparing viewer…
PDB8GLP · 1.67 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.24Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.00 [0.00–0.24]
RankingsWhere RPS13 stands among ~20K protein-coding genes
  • #1,265of 20,598
    Most Researched285 · top 10%
  • #803of 1,025
    FDA-Approved Drug Targets1
  • #682of 17,882
    Most Constrained (LOEUF)0.24 · top 5%
Genes detectedRPS13
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
RPS13, a potential universal reference gene for normalisation of gene expression in multiple human normal and cancer tissue samples.
PMID: 34657252
Mol Biol Rep · 2021
1.00
2
[Prokaryotic expression and purification of RPS13 and preparation of polyclonal antibody against RPS13].
PMID: 17428396
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi · 2007
0.90
3
The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers.
PMID: 39970212
Sci Adv · 2025
0.80
4
Comparative Proteomic Analysis of Irradiation-Induced Radioresistant Breast Cancer Cells Using Label-Free Quantitation.
PMID: 37919065
Front Biosci (Landmark Ed) · 2023
0.76
5
Exploration of RNA-binding proteins identified RPS27 as a potential regulator associated with Kaposi's sarcoma development.
PMID: 40016701
BMC Cancer · 2025
0.70